Results 121 to 130 of about 548,458 (391)

Angiogenesis as a Therapeutic Target of (Poly)phenols: Tackling Cancer and Vascular‐Related Complications

Molecular Nutrition &Food Research, EarlyView.
(Poly)phenols constitute a source of natural therapeutic molecules capable of targeting angiogenesis in different scenarios. This review summarizes the current evidence of the role of (poly)phenols in modulating angiogenesis. The reader can find a compilation of preclinical and human investigations describing pro‐ and anti‐angiogenic effects of these ...
María Ángeles Ávila‐Gálvez, Antonio Vico‐Padilla, Claus Schneider, Juan Carlos Espín, Antonio González‐Sarrías, Juan Antonio Giménez‐Bastida   +5 more
wiley   +1 more source

Medical therapy for polycystic liver disease [PDF]

The Annals of The Royal College of Surgeons of England, 2016
Introduction Somatostatin analogues and rapamycin inhibitors are two classes of drugs available for the management of polycystic liver disease but their overall impact is not clearly established. This article systematically reviews the literature on the medical management of polycystic liver disease.
S Khan, Ashley R. Dennison, G Garcea
openaire   +3 more sources

Generational differences in associations between health conditions in young women and BMI categories

Obesity, EarlyView.
Abstract Objective The objective of this study was to investigate whether the associations between BMI categories and the age‐specific prevalence of health conditions common in young women differed across generations. Methods Data were from the Australian Longitudinal Study on Women's Health for participants born between 1973 and 1978 or 1989 and 1995 ...
Annette J. Dobson, Chen Liang, Gita D. Mishra   +2 more
wiley   +1 more source

Combined left hepatectomy with fenestration and using a harmonic scalpel, fibrin glue and closed suction drainage to prevent bile leakage and ascites in the management of symptomatic polycystic liver disease: a case report

Journal of Medical Case Reports, 2009
Introduction Surgical treatment is the usual therapy for patients with polycystic liver disease and with severe symptoms, yet the results of surgery are often disappointing and the optimal surgical approach is uncertain.
Kosmidis Christopher, Efthimiadis Christopher, Anthimidis George, Levva Sofia, Prousalidis John, Papapolychroniadis Konstantinos, Fachantidis Epaminondas   +6 more
doaj   +1 more source

Complications of Cushing's syndrome: state of the art [PDF]

, 2016
Cushing's syndrome is a serious endocrine disease caused by chronic, autonomous, and excessive secretion of cortisol. The syndrome is associated with increased mortality and impaired quality of life because of the occurrence of comorbidities.
Biller, Beverly M. K, Colao, Annamaria, De Martino, Maria Cristina, Isidori, Andrea, Newell Price, John, Pivonello, Rosario   +5 more
core   +1 more source

Epidemiology and mortality of liver abscess in end-stage renal disease dialysis patients: Taiwan national cohort study.

PLoS ONE, 2014
Background and objectivesTo determine the incidence rates and mortality of liver abscess in ESRD patients on dialysis.Design setting participants & measurementsUsing Taiwan's National Health Insurance Research Database, we collected data from all ESRD ...
Chon-Seng Hong, Kun-Ming Chung, Po-Chang Huang, Jhi-Joung Wang, Chun-Ming Yang, Chin-Chen Chu, Chung-Ching Chio, Fu-Lin Chang, Chih-Chiang Chien   +8 more
doaj   +1 more source

Computation of Total Kidney Volume from CT images in Autosomal Dominant Polycystic Kidney Disease using Multi-Task 3D Convolutional Neural Networks [PDF]

arXiv, 2018
Autosomal Dominant Polycystic Kidney Disease (ADPKD) characterized by progressive growth of renal cysts is the most prevalent and potentially lethal monogenic renal disease, affecting one in every 500-100 people. Total Kidney Volume (TKV) and its growth computed from Computed Tomography images has been accepted as an essential prognostic marker for ...
arxiv  

Liver Fibrosis and NAS scoring from CT images using self-supervised learning and texture encoding [PDF]

arXiv, 2021
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver diseases (CLD) which can progress to liver cancer. The severity and treatment of NAFLD is determined by NAFLD Activity Scores (NAS)and liver fibrosis stage, which are usually obtained from liver biopsy.
arxiv  

Polycystic liver disease: Hepatic venous outflow obstruction lesions of the noncystic parenchyma have major consequences

Hepatology, 2018
In patients with polycystic liver disease (PLD), development of cysts induces hepatic venous outflow obstruction (HVOO) and parenchymal modifications, challenging the paradigm of a normal noncystic liver parenchyma.
L. Barbier, M. Ronot, B. Aussilhou, F. Cauchy, C. Francoz, V. Vilgrain, O. Soubrane, V. Paradis, J. Belghiti   +8 more
semanticscholar   +1 more source

Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease

Case Reports in Nephrology and Dialysis, 2017
A 44-year-old Japanese woman with autosomal dominant polycystic kidney disease was admitted to our hospital for evaluation of abdominal distension. Her eGFR was 53.7 mL/min/1.73 m2. Total kidney volume was 2,614 mL.
Hiroki Mizuno, Junichi Hoshino, Tatsuya Suwabe, Keiichi Sumida, Akinari Sekine, Yoichi Oshima, Masahiko Oguro, Kyohei Kunizawa, Masahiro Kawada, Rikako Hiramatsu, Noriko Hayami, Eiko Hasegawa, Masayuki Yamanouchi, Naoki Sawa, Kenmei Takaichi, Yoshifumi Ubara   +15 more
doaj   +1 more source